Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2014. The document serves as a notification of a transaction involving a Connected Person under the Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction and does not contain financial performance data.
Material Changes
The filing details the acquisition of 13 Ordinary Shares by Mrs. K Thomson, a Connected Person. The shares were purchased on July 10, 2014, at a price of 1,561.76 pence per share. This transaction resulted from the reinvestment of dividends paid on shares held in the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the share price of 1,561.76 pence per Ordinary Share on July 10, 2014.
- Confirm the total number of shares acquired (13) by Mrs. K Thomson via the ShareReward Plan.
- Note that this filing does not contain quarterly or annual financial results.